Home/Filings/4/A/0001415889-21-001296
4/A//SEC Filing

Yang Allen 4/A

Accession 0001415889-21-001296

CIK 0001326732other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 8:00 PM ET

Size

5.7 KB

Accession

0001415889-21-001296

Insider Transaction Report

Form 4/AAmended
Period: 2019-12-16
Yang Allen
SVP, Chief Medical Officer
Transactions
  • Award

    Stock Options

    2019-12-16+62,30062,300 total
    Exercise: $37.60Exp: 2029-12-15Common Stock (62,300 underlying)
Footnotes (2)
  • [F1]The initial filing incorrectly listed the exercise price at $37.59 per share due to an administrative error.
  • [F2]1/4th of the shares vest one year after December 16, 2019 (the "Vesting Commencement Date"); the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date, subject to the optionholder's Continuous Service (as defined in the 2013 Equity Incentive Plan) as of each such date.

Issuer

Xencor Inc

CIK 0001326732

Entity typeother

Related Parties

1
  • filerCIK 0001797034

Filing Metadata

Form type
4/A
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 8:00 PM ET
Size
5.7 KB